Press releases
- Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
- Agenus Announces Reverse Stock Split of Common Stock
- Agenus Reports Fourth Quarter and Full Year 2023 Results
- Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
- Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
- Agenus to Participate in Leerink Partners Global Biopharma Conference
More ▼
Key statistics
As of last trade Agenus Inc (AJ8:FRA) traded at 7.80, 0.00% above its 52-week low of 7.80, set on Apr 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | 6.10 |
Offer | 6.23 |
Previous close | 7.80 |
Average volume | -- |
---|---|
Shares outstanding | 20.28m |
Free float | 20.03m |
P/E (TTM) | -- |
Market cap | 243.62m USD |
EPS (TTM) | -13.95 USD |
Data delayed at least 15 minutes, as of Apr 11 2024.
More ▼